Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1997;96:864-873

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Parodi, O.
Right arrow Articles by L'Abbate, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Parodi, O.
Right arrow Articles by L'Abbate, A.

(Circulation. 1997;96:864-873.)
© 1997 American Heart Association, Inc.


Articles

Comparative Effects of Enalapril and Verapamil on Myocardial Blood Flow in Systemic Hypertension

Oberdan Parodi, MD; Danilo Neglia, MD; Carlo Palombo, MD; Gianmario Sambuceti, MD; Assuero Giorgetti, MD; Claudio Marabotti, MD; Michela Gallopin, MD; Ignazio Simonetti, MD; ; Antonio L'Abbate, MD

From the Institute of Clinical Physiology of the National Council of Research, Pisa, Italy, and the Istituto di Clinica Medica Generale e Cardiologia, Università di Firenze (Italy) (M.G., I.S.).

Correspondence to Oberdan Parodi, MD, CNR Institute of Clinical Physiology, Via Paolo Savi, 8, I-56100, Pisa, Italy. E-mail parodi{at}po.ifc.pi.cnr.it

Background The comparative effects of calcium channel blockers and ACE inhibitors on myocardial blood flow (MBF) in hypertensive patients after long-term treatment are still unknown.

Methods and Results Twenty hypertensive subjects with normal coronary arteries were randomly assigned to verapamil 240 to 480 mg/d or enalapril 10 to 40 mg/d. MBF was quantified at rest, during pacing tachycardia, and after dipyridamole by positron emission tomography and 13N-ammonia before and 6 months after treatment after 1 week of pharmacological washout. In both groups, blood pressure and heart rate during flow measurements were not different before and after therapy. Before treatment, mean MBF at rest, during pacing tachycardia, and after dipyridamole infusion was similar in the two groups; however, pacing and dipyridamole flows were significantly lower than those obtained in a control group of normotensive subjects. After treatment, in the enalapril-treated patients, MBF did not change in the three study conditions. In the verapamil-treated patients, MBF did not change at rest and significantly increased during pacing and after dipyridamole. The inhomogeneity of regional MBF distribution, evaluated from the coefficient of variation, decreased at rest after both treatments and, in the enalapril group, also during pacing. No relation was found between changes in MBF and changes in left ventricular mass.

Conclusions In arterial hypertension, MBF during pacing tachycardia and after dipyridamole is impaired. Successful therapy with verapamil increases MBF response to these stimuli, independent of changes in perfusion pressure and left ventricular mass. These results suggest that verapamil directly improves coronary microcirculatory function in hypertension. Enalapril does not significantly change MBF but reduces the inhomogeneity of regional flow distribution.


Key Words: hypertension • calcium channels • tomography • microcirculation




This article has been cited by other articles:


Home page
HypertensionHome page
R. H. Fagard, H. Celis, L. Thijs, and S. Wouters
Regression of Left Ventricular Mass by Antihypertensive Treatment: A Meta-Analysis of Randomized Comparative Studies
Hypertension, November 1, 2009; 54(5): 1084 - 1091.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
N. Koivuviita, R. Tertti, M. Jarvisalo, M. Pietila, J. Hannukainen, J. Sundell, P. Nuutila, J. Knuuti, and K. Metsarinne
Increased basal myocardial perfusion in patients with chronic kidney disease without symptomatic coronary artery disease
Nephrol. Dial. Transplant., September 1, 2009; 24(9): 2773 - 2779.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
N. H. Buus, M. Bottcher, C. G. Jorgensen, K. L. Christensen, K. Thygesen, T. T. Nielsen, and M. J. Mulvany
Myocardial Perfusion During Long-Term Angiotensin-Converting Enzyme Inhibition or {beta}-Blockade in Patients With Essential Hypertension
Hypertension, October 1, 2004; 44(4): 465 - 470.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Rajappan, O. E. Rimoldi, P. G. Camici, N. G. Bellenger, D. J. Pennell, and D. J. Sheridan
Functional Changes in Coronary Microcirculation After Valve Replacement in Patients With Aortic Stenosis
Circulation, July 1, 2003; 107(25): 3170 - 3175.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Yada, M. Goto, O. Hiramatsu, H. Tachibana, E. Toyota, H. Nakamoto, Y. Ogasawara, H. Matsuda, K. Arakawa, K. Hayashi, et al.
In vivo visualization of subendocardial arteriolar response in renovascular hypertensive hearts
Am J Physiol Heart Circ Physiol, May 1, 2003; 284(5): H1785 - H1792.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Kozakova, G. de Simone, C. Morizzo, and C. Palombo
Coronary Vasodilator Capacity and Hypertension-Induced Increase in Left Ventricular Mass
Hypertension, February 1, 2003; 41(2): 224 - 229.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
O. O. Akinboboye, R. u-L. Chou, and S. R. Bergmann
Augmentation of myocardial blood flow in hypertensive heart disease by angiotensin antagonists: A comparison of lisinopril and losartan
J. Am. Coll. Cardiol., August 21, 2002; 40(4): 703 - 709.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
N. H. Buus, M. Bottcher, F. Hermansen, M. Sander, T. T. Nielsen, and M. J. Mulvany
Influence of Nitric Oxide Synthase and Adrenergic Inhibition on Adenosine-Induced Myocardial Hyperemia
Circulation, November 6, 2001; 104(19): 2305 - 2310.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Kozakova, F. Galetta, L. Gregorini, G. Bigalli, F. Franzoni, C. Giusti, and C. Palombo
Coronary Vasodilator Capacity and Epicardial Vessel Remodeling in Physiological and Hypertensive Hypertrophy
Hypertension, September 1, 2000; 36(3): 343 - 349.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. Schwitter, T. DeMarco, S. Kneifel, G. K. von Schulthess, M. C. Jorg, H. Arheden, S. Ruhm, K. Stumpe, A. Buck, W. W. Parmley, et al.
Magnetic Resonance-Based Assessment of Global Coronary Flow and Flow Reserve and Its Relation to Left Ventricular Functional Parameters : A Comparison With Positron Emission Tomography
Circulation, June 13, 2000; 101(23): 2696 - 2702.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. C. Nielsen, M. Bottcher, T. Toftegaard Nielsen, A. K. Pedersen, and H. R. Andersen
Regional myocardial blood flow in patients with sick sinus syndrome randomized to long-term single chamber atrial or dual chamber pacing--effect of pacing mode and rate
J. Am. Coll. Cardiol., May 1, 2000; 35(6): 1453 - 1461.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. Laine, C. Katoh, M. Luotolahti, H. Yki-Jarvinen, I. Kantola, A. Jula, T. O. Takala, U. Ruotsalainen, H. Iida, M. Haaparanta, et al.
Myocardial Oxygen Consumption Is Unchanged but Efficiency Is Reduced in Patients With Essential Hypertension and Left Ventricular Hypertrophy
Circulation, December 14, 1999; 100(24): 2425 - 2430.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
T. J. Anderson
Assessment and treatment of endothelial dysfunction in humans
J. Am. Coll. Cardiol., September 1, 1999; 34(3): 631 - 638.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
G. Fragasso, C. Lu, P. Dabrowski, P. Pagnotta, I. Sheiban, and S. L. Chierchia
Comparison of stress/rest myocardial perfusion tomography, dipyridamole and dobutamine stress echocardiography for the detection of coronary disease in hypertensive patients with chest pain and positive exercise test
J. Am. Coll. Cardiol., August 1, 1999; 34(2): 441 - 447.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
B Schwartzkopff and B.E Strauer
Squeezing tubes: a case of remodeling and regulation: Coronary reserve in hypertensive heart disease
Cardiovasc Res, October 1, 1998; 40(1): 4 - 8.
[Full Text] [PDF]